Several jurisdictions have implemented legalization policies for non-medical cannabis, mainly towards improving public health and reducing illegal cannabis markets and crime. As some legalization initiatives are approaching maturity, conducting policy impact assessments has become timely. Emerging data, however, suggest rather mixed pictures for key outcomes and indicators. While many key health-related indicators show increases in adverse outcomes, improvements are shown for main crime-related outcomes associated with legalization. However, legalization policies are evaluated predominantly by utilizing separate approaches for the health outcomes and crime-related indicators, while comprehensive policy assessments require meaningful integration of all related indicators. We provide suggestions for an integrated approach to assessing cannabis legalization policies concerning health and crime-related outcomes. This approach is also valuable for policymakers and other stakeholders to create an empirical basis for relative valuations and choices regarding cannabis legalization's main policy outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1057/s41271-025-00552-2 | DOI Listing |
J Adolesc Health
January 2025
STAD, Stockholm Prevents Alcohol and Drug Problems, Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Purpose: In 1996, a multicomponent alcohol prevention intervention was launched and later institutionalized in Stockholm. This study examines the long-term effects of the program on compliance with the legal minimum age limit for alcohol service at licensed premises.
Methods: The intervention comprised community mobilization and collaboration, training, and enforcement aimed at preventing alcohol service to underage (<18 years) or obviously intoxicated patrons.
Front Health Serv
January 2025
School of Healthcare, University of Leeds, Leeds, United Kingdom.
Background: There is a growing international policy focus on involving those affected by healthcare safety incidents, in subsequent investigations. Nonetheless, there remains little UK-based evidence exploring how this relates to the experiences of those affected over time, including the factors influencing decisions to litigate.
Aims: We aimed to explore the experiences of patients, families, staff and legal representatives affected by safety incidents over time, and the factors influencing decisions to litigate.
J Pharm Policy Pract
January 2025
Global Health Centre, Graduate Institute of International and Development Studies, Geneva, Switzerland.
Background: The current mainstream pharmaceutical innovation system (PIS) is driven by the market-based logic of charging the highest prices societies will bear. Outcomes include unaffordable medicines, restricted access and pressure on health budgets. How can the innovation system change to deliver fairly-priced medicines?
Methods: We inductively developed a novel conceptual framework of the PIS as a complex adaptive system (CAS) analogous to a forest.
Drug Alcohol Depend Rep
September 2024
School of Social Work, Boston College, Chestnut Hill, MA, USA.
Background: To understand the impact of laws raising minimum legal sales age for tobacco products to age 21, researchers and policymakers need to recognize how recommended policy components vary across states. This paper identified and reviewed policy components across 43 jurisdictions that have enacted Tobacco 21 (T21) laws since 2015.
Methods: Using NexisUni's database of state laws and legislation, we evaluated T21 laws in effect as of January 2024 and assessed for the incorporation of six components recommended in proposed model legislation: 1) age verification; 2) tobacco retailer licensing; 3) provisions to suspend or revoke a license; 4) unannounced inspections; 5) retailer civil or criminal penalties; and 6) provisions that allow for more stringent local laws.
J Public Health Policy
January 2025
Research Centre, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Several jurisdictions have implemented legalization policies for non-medical cannabis, mainly towards improving public health and reducing illegal cannabis markets and crime. As some legalization initiatives are approaching maturity, conducting policy impact assessments has become timely. Emerging data, however, suggest rather mixed pictures for key outcomes and indicators.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!